Skip to main content
Premium Trial:

Request an Annual Quote

Eisai Subscribes to Incyte s LifeSeq Gold and ZooSeq

NEW YORK, April 9 - Eisai, a Japanese health care and pharmaceutical company, has signed a multi-year subscription to Incyte Genomics' LifeSeq Gold human sequence and ZooSeq animal model databases, the company said Monday.

Researchers at Eisai, which is based in Tokyo, will have 24-hour online access to the databases and to information technology support, Incyte said in a statement.

"We recognize that genome-based research is an integral component in today's drug discovery and when we completed our analysis of the various genomic data product offerings, we became convinced that the collaboration with Incyte Genomics will greatly strengthen our genome-based research activities," said Aishin Shinoda, senior vice president of Eisai, in a statement.

Financial terms of the deal were not disclosed.

As a LifeSeq Gold subscriber, Eisai will access a database that integrates proprietary expressed tag sequence and full-length gene sequence, as well as cDNA clones of the genes in the database. ZooSeq is a similar database containing sequences from rat, mouse, dog, and monkey genomes.

Incyte's other customers in Japan include Sumitomo Pharmaceuticals and Sankyo.  
The Scan

Study Reveals Details of SARS-CoV-2 Spread Across Brazil

A genomic analysis in Nature Microbiology explores how SARS-CoV-2 spread into, across, and from Brazil.

New Study Highlights Utility of Mutation Testing in Anaplastic Thyroid Cancer

Genetic mutations in BRAF and RAS are associated with patient outcomes in anaplastic thyroid carcinoma, a new JCO Precision Oncology study reports.

Study Points to Increased Risk of Dangerous Blood Clots in COVID-19 Patients

An analysis in JAMA Internal Medicine finds that even mild COVID-19 increases risk of venous thromboembolism.

Y Chromosome Study Reveals Details on Timing of Human Settlement in Americas

A Y chromosome-based analysis suggests South America may have first been settled more than 18,000 years ago, according to a new PLOS One study.